-
News | 2022.01.12
French Prime Minister Jean Castex salutes the Institut Pasteur's expertise on emerging infectious diseases
French Prime Minister Jean Castex, accompanied by Frédérique Vidal, Minister of Higher Education, Research and Innovation, visited the Institut Pasteur on Monday January 10, 2022, to salute the efforts of scientists in the ongoing battle against COVID-19. The visit was an opportunity to highlight the need to strengthen preparedness for future emerging diseases. It was also an auspicious moment...
-
Document de presse | 2022.01.24
Pierre Buffet appointed as Medical Director of the Institut Pasteur
Professor Pierre Buffet has been appointed as Medical Director of the Institut Pasteur. Pierre Buffet took up his post on January 3, 2022 within the Institut Pasteur's Department of Scientific Affairs. Professor Pierre Buffet has been appointed as Medical Director within the Institut Pasteur's Department of Scientific Affairs, led by Senior Executive Scientific Vice-President Christophe d'...
-
Document de presse | 2022.06.07
Institut Pasteur and MSDAVENIR sign a partnership to improve strategies for controlling the spread of vector-borne viral diseases like Zika
The Institut Pasteur and MSDAVENIR, a health research endowment fund by MSD, signed an important partnership to anticipate responses to future vector-borne viral epidemics today. The partnership, worth more than €1.7 million, will support the INTRANZIGEANT project led by Dr. Louis Lambrechts, head of the Virus-Insect Interactions Unit, and Xavier Montagutelli, head of the Mouse Genetics...
-
News | 2022.08.24
ZIKAlliance project: Zika vector competence data reveals risks of outbreaks
A publication published this summer looks back at the contribution of the European ZIKAlliance project, launched in 2016 following the Zika epidemic in the Pacific Islands and America. A global analysis of the competence of potential vectors was carried out, the most comprehensive study of vector competence to date using the same protocols. This study reminds us that vector-borne diseases are...
-
News | 2023.01.30
Hepatitis B: towards better treatment for infected individuals in Africa
With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.
-
News | 2023.02.28
Health crises, information crises: exploring the roots of the term "infodemic"
How do the epidemiological and media dimensions of a health crisis fit together? How is the spread of a virus linked to the spread of information about it? Several scientists, communication experts and ethics specialists came together to explore these questions at a conference held at the Institut Pasteur in December.
-
Document de presse | 2023.06.08
The tiger mosquito can transmit the chikungunya virus in temperate conditions
The tiger mosquito Aedes albopictus, native to Southeast Asia, is one of two vectors for transmission of the chikungunya virus to humans. Scientists at the Institut Pasteur and Université Paris Cité have shown that this mosquito can acquire the ability to transmit the chikungunya virus as effectively at 20°C as at 28°C. The spread of the tiger mosquito in temperate climates could therefore result...
-
Fiche maladie | 2023.11.06
Crimean-Congo hemorrhagic fever
Crimean-Congo hemorrhagic fever (CCHF) is a disease caused by a virus of the same name. In most cases, the infection is mild, but it can be severe or even fatal. The main route of transmission of the virus to humans is bites from ticks of the genus Hyalomma.
-
Document de presse | 2023.12.06
Plasmodium vivax malaria: infections may be largely underestimated in sub-Saharan Africa
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
-
Document de presse | 2023.12.05
COVID-19: the persistence of SARS-CoV-2 in the lungs and the role of innate immunity
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung...